At-home Molecular Testing Market Outlook (2023 to 2033)

The at-home molecular testing market size is projected to be worth USD 10.2 billion in 2023. The market is likely to surpass USD 18.1 billion by 2033 at a CAGR of 5.9% during the forecast period. Increased infectious illnesses and an increase in the number of diabetes patients around the world are driving the market expansion.

For instance, monkey pox and other infectious illnesses pose a severe threat to public health and economic development in all nations. Additionally, the need for early detection of various diseases and growing awareness of them are fueling market expansion.

The prospective growth of the at-home testing market was influenced by the population's growing awareness of home care testing.

Other Drivers Propelling the Demand for At-home Molecular Testing Market include:

  • Due to the rise in diabetes prevalence, there is an increasing requirement for the market for molecular testing. As of 2021, 537 million individuals worldwide or about 10% of all adults aged 20 to 79 were living with diabetes, according to the latest recent IDF data.
  • The production of the newest at-home testing tools and kits, as well as a growing understanding of the advantages offered by these services, are promoting market expansion.
  • At-home kits are simple to obtain and are readily available at pharmacies and online retailers. Additionally, these at-home testing tools are accessible over the counter. As a result, the kits' widespread availability is promoting market expansion.
  • The market for at-home testing kits or medical devices with improved healthcare services has grown as a result of an increase in R&D activity in the field of personalized self-assessment kits for the diagnosis of HIV illness

Challenges for Companies /Manufacturers in the At-home Molecular Testing Market:

  • At home molecular testing kits or devices have undoubtedly eased the process of confirming the persons concern. However, uncertainty about the accuracy of the result is a key challenges for larger adoption.
  • Other restraining factor for at-home molecular testing market is the complex and evolving regulatory landscape. Compliance with the regulations can be time-consuming and costly for companies, limiting their ability to bring new products to market.
  • Test menu for at home tests are relatively limited compared to traditional laboratory-based tests. Complex or specialized tests may still require a visit to a healthcare facility, limiting the market potential of at-home testing.

Opportunities in the At-home Molecular Testing Market Industry:

  • Rising demand for personalized medicine and the increasing focus on personalized medicine presents a significant opportunity for at-home molecular testing.
  • Advances in technology, such as improved sample collection methods, more sensitive and accurate molecular assays, and user-friendly testing kits, will enhance the overall user experience, making testing easier and more reliable.
  • The significant financial investments made in healthcare and life science research in emerging markets are crucial in modernizing the laboratory infrastructure in developing nations, which promotes the expanding use of molecular diagnostics.

Latest Trends in the At-home Molecular Testing Market:

  • At-home testing kits now cover a wide range of health conditions and concerns, including hormone levels, fertility, food sensitivities, STIs, cholesterol levels, vitamin deficiencies, and more. This diversification allows individuals to gain insights into various aspects of their health and well-being.
  • The demand for accessible and convenient testing options has surged, leading to the rapid development and availability of at-home testing kits.
  • Hormone testing has gained popularity in the at-home testing kits market, particularly among individuals interested in monitoring and optimizing their hormonal balance.
Attributes Details
At-home Molecular Testing Market Size (2023) USD 10.2 billion
At-home Molecular Testing Market Projected Size (2033) USD 18.1 billion
Value CAGR (2023 to 2033) 5.9%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2017 to 2022 At-home Molecular Testing Market Demand Outlook Compared to 2023 to 2033 Forecast

From 2017 to 2022, the global at-home molecular testing market experienced a CAGR of 5.4%, reaching a market size of USD 10.2 billion in 2023.

From 2017 to 2022, the global at-home molecular testing market industry witnessed steady growth due to the increased awareness and acceptance of at-home molecular testing. The at-home molecular testing market was in its infancy, primarily focused on genetic testing for ancestry and genealogy purposes.

ompanies like 23andMe and AncestryDNA gained popularity, attracting consumers interested in exploring their genetic heritage. The market witnessed increased awareness and acceptance of at-home molecular testing during this period. More consumers recognized the potential benefits of understanding their genetic health risks and gaining personalized insights. The market diversified to include tests for traits, wellness, and lifestyle factors, such as diet and exercise recommendations based on genetic profiles.

Future Forecast for At-home Molecular Testing Market Industry:

Looking ahead, the global at-home molecular testing market industry is expected to rise at a CAGR of 5.9% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 18.1 billion by 2033.

The at-home molecular testing market industry is expected to continue its growth trajectory from 2023 to 2033. The at-home molecular testing market is expected to witness an expansion of the test menu, offering a wider range of genetic and molecular tests.

As scientific knowledge expands, more disease markers, genetic variants, and actionable insights will be identified, leading to the development of new tests. This diversification will attract a larger consumer base and drive market growth.

The growing focus on personalized medicine and preventive healthcare will fuel the demand for at-home molecular testing. Individuals are increasingly interested in understanding their genetic predispositions, optimizing their health choices, and monitoring disease risks. At-home testing provides a convenient and accessible means to achieve these goals.

Country-Wise Insights

At-home Molecular Testing Market to Surge in the United States Due to Rising Prevalence of Diabetes.

Country The United States
Market Size (USD billion) by End of Forecast Period (2033) USD 5.6 billion
CAGR % 2023 to End of Forecast (2033) 7.2%

The at-home molecular testing market industry in the United States is expected to reach a market size of USD 5.6 billion by 2033, expanding at a CAGR of 7.2%. Due to the rising demand for at home diabetic testing kits. In the United States, more than 130 million persons have diabetes or prediabetes, according to the Centers for Disease Control and Prevention 2022. Such growing prevalence of diabetes in the country, the demand for at home molecular testing market is high.

Rising Demand for At-home Molecular Testing Market is Due to the Growing Awareness Regarding Personalized Medicine.

Country The United Kingdom
Market Size (USD billion) by End of Forecast Period (2033) USD 689.1 million
CAGR % 2023 to End of Forecast (2033) 6.8%

The at-home molecular testing market industry in the United Kingdom is expected to reach a market share of USD 689.1 million, expanding at a CAGR of 6.8% during the forecast period. The United Kingdom market is projected to growth of the market due to the growing personalized medicine initiatives. The United Kingdom has been at the forefront of personalized medicine initiatives, aiming to provide tailored healthcare based on an individual's genetic profile. At-home molecular testing plays a crucial role in these initiatives, allowing individuals to access genetic information, identify disease risks, and participate in research studies to advance personalized healthcare.

Notable Growth Expected in China's At-home Molecular Testing Market as Prevalence of Chronic Diseases in the Country.

Country China
Market Size (USD billion) by End of Forecast Period (2033) USD 1.30 billion
CAGR % 2023 to End of Forecast (2033) 5.1%

The at-home molecular testing market industry in China is anticipated to reach a market size of USD 1.30 billion, moving at a CAGR of 5.1% during the forecast period. The at-home molecular testing market industry in China is expected to grow prominently due to the increasing chronic disease. China is facing a rising burden of chronic diseases, such as cardiovascular diseases, diabetes, and cancer.

At-home molecular testing offers a way for individuals to monitor their health, detect diseases early, and take preventive measures. The ability to access testing from the comfort of their homes aligns with the increasing emphasis on preventive healthcare.

Growing Technological Advancement and E-commerce Development to Drive Market Growth in Japan

Country Japan
Market Size (USD billion) by End of Forecast Period (2033) USD 1.12 billion
CAGR % 2023 to End of Forecast (2033) 5.8%

The at-home molecular testing market industry in Japan is estimated to reach a market size of USD 1.12 billion by 2033, thriving at a CAGR of 5.8%. The market in Japan is predicted to grow because of the growing technological advancements.

Japan has a well-established e-commerce infrastructure and a high penetration of smartphones. This has facilitated the growth of online platforms and marketplaces for at-home molecular testing kits. The ease of purchasing and accessing these kits online has contributed to the rising demand in the country.

Demand for At-home Molecular Testing Market is Rising Due to Increasing Awareness and Acceptance of the Market.

Country South Korea
Market Size (USD billion) by End of Forecast Period (2033) USD 253.9 million
CAGR % 2023 to End of Forecast (2033) 3.6%

The at-home molecular testing market industry in South Korea is expected to reach a market size of USD 253.9 million, expanding at a CAGR of 3.6% during the forecast period. The market in South Korea is forecasted to witness growth due to the increased awareness and acceptance. There has been a growing awareness and acceptance of at-home molecular testing among the general population in the South Korea. Consumers are increasingly interested in understanding their genetic heritage, health risks, and ancestry. This has contributed to the rising demand for at-home genetic testing kits.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-Wise Insights

Cassette Test Devices to Dominate At-home Molecular Testing Market Industry with 6.7% CAGR through 2033

The cassettes are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 due to its rapid testing procedures, high efficiency, and improved testing kits.

According to the needs of the consumer, diagnostic cassettes for rapid test for diagnostic kits can be used in a single way or many ways (two or four ways). For immediate results, Plastic Cassettes for Rapid Test (Cassettes for Diagnostic Kits) are frequently utilized. For the best outcomes, it also guarantees improved buffer flow with the right pressure points through the strip.

How the Infectious Diseases are Driving At-home Molecular Testing Market?

Infectious diseases are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 as incidences of infectious diseases in the globe is on the rise.

The prevalence of infectious diseases in developed and developing regions will have a beneficial impact on market growth. The increasing number of prescriptions for at-home infectious illness diagnostic tests is due to the diagnosis and management of such infections.

Which Sample Type is Widely Adopted the At-home Molecular Testing Market?

The blood sample segment is expected to dominate the at-home molecular testing market industry with a CAGR of 5.5% from 2023 to 2033 and is expected to hold market share of 42.4% in 2023. Blood testing are extremely common. They aid clinicians in the detection of certain diseases and ailments.

They also aid in the evaluation of organ function and the effectiveness of treatments. One of the most popular blood tests is the complete blood count (CBC). It is frequently performed as part of a standard checkup. This test evaluates a variety of blood components, including red blood cells, white blood cells, and platelets.

Which Distribution Channel Is Widely Adopted In the Market?

The drug store in dominating the at home molecular testing market with the CAGR of 6.2%. The ease of availability of the testing kits without prescription in the drug store the adoption is high.

How Key Players Stay Competitive in the At-home Molecular Testing Market Industry?

The at-home molecular testing sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.

Key Strategies Used by the Participants

  • Product Development

To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.

  • Strategic Alliances & Collaborations

Strategic alliances and partnerships with other businesses are regularly formed by major players in an industry to take advantage of each other's advantages and expand their market reach. Through such arrangements, businesses may also obtain access to new technologies and markets.

  • Expansion into Emerging Markets

The market for at-home molecular testing is rising quickly in developing nations like China and India. To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites.

  • Acquisitions and mergers

Key companies in the at-home molecular testing market routinely employ mergers and acquisitions to strengthen their market positions, broaden their product offerings, and enter new markets.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Players in the At-home Molecular Testing Market Industry

  • Abbott
  • ACON Laboratories, Inc.
  • Rapikit
  • Becton and Dickinson
  • Cardinal Health
  • B. Braun Melsungen AG
  • Piramal Enterprises Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation
  • Bionime Corporation
  • SA Scientific
  • ARKRAY USA, Inc.
  • Nova Biomedical
  • AdvaCare Pharma
  • AccuBioTech Co., Ltd.
  • Atlas Medical UK
  • TaiDoc Technology Corporation
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd
  • Sensing Self
  • PTE. Ltd
  • Atomo Diagnostics
  • Mankind Pharma

Key Developments in the At-home Molecular Testing Market:

  • On 23rd April 2022, Prega News, a pregnancy test kit brand owned by Mankind Pharma, has introduced a brand-new and sophisticated pregnancy detection test kit for the Indian market.
  • 10th June, 2022, Mylab Discovery Solutions, a biotech startup, has entered the women's healthcare market with the release of the PregaScreen home pregnancy test kit.

Segmentation Analysis of the At-home Molecular Testing Market

By Product:

  • Cassettes
  • Strips
  • Test Panels
  • Dip Cards
  • Midstreams
  • Others

By Test Type:

  • Pregnancy Tests
  • HIV Tests
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Tests
  • Drug Abuse Tests
  • Others

By Sample Type:

  • Urine
  • Blood
  • Saliva
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

Frequently Asked Questions

What is the At-home Molecular Testing market CAGR for 2033?

The at-home molecular testing market CAGR for 2033 is 5.9%.

Which is the Leading Region in the At-home Molecular Testing market?

The North America region is the leading region in the market.

What is the projected market value of the global At-home Molecular Testing market for 2033?

The projected market value of the market for 2033 is US$ 10.2 billion.

How Key Players are Developing the At-home Molecular Testing Market?

Key players are developing the market by developing innovative tests.

Which are the Major Countries in the At-home Molecular Testing Market?

China, India, the United States, Japan, and Germany are the major countries in this market.

Table of Content
  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Value Added Insights
  • 5. Market Background
  • 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033
  • 7. Global Market - Pricing Analysis
  • 8. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
  • 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
    • 9.1. Cassettes
    • 9.2. Strips
    • 9.3. Test Panels
    • 9.4. Dip Cards
    • 9.5. Midstreams
  • 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test Type
    • 10.1. Pregnancy Tests
    • 10.2. HIV Tests
    • 10.3. Diabetes
    • 10.4. Infectious Diseases
    • 10.5. Glucose Tests
    • 10.6. Ovulation Predictor Tests
    • 10.7. Drug Abuse Tests
    • 10.8. Others
  • 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type
    • 11.1. Urine
    • 11.2. Blood
    • 11.3. Saliva
    • 11.4. Others
  • 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
    • 12.1. Retail Pharmacies
    • 12.2. Drug Stores
    • 12.3. Supermarkets/Hypermarkets
    • 12.4. Online Pharmacies
  • 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
    • 13.1. North America
    • 13.2. Latin America
    • 13.3. Europe
    • 13.4. South Asia
    • 13.5. East Asia
    • 13.6. Oceania
    • 13.7. Middle East and Africa (MEA)
  • 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
  • 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
  • 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
  • 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
  • 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
  • 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
  • 20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
  • 21. Market Structure Analysis
  • 22. Competition Analysis
    • 22.1. Abbott
    • 22.2. Rapikit
    • 22.3. Becton and Dickinson
    • 22.4. Cardinal Health
    • 22.5. B. Braun Melsungen AG
    • 22.6. Piramal Enterprises Ltd.
    • 22.7. Siemens Healthcare GmbH
    • 22.8. Quidel Corporation
    • 22.9. Bionime Corporation
    • 22.10. SA Scientific
    • 22.11. ARKRAY USA, Inc.
    • 22.12. Nova Biomedical
    • 22.13. AdvaCare Pharma
    • 22.14. AccuBioTech Co., Ltd.
    • 22.15. Atlas Medical UK
    • 22.16. TaiDoc Technology Corporation
    • 22.17. Drägerwerk AG & Co. KGaA
    • 22.18. F. Hoffmann-La Roche Ltd
    • 22.19. Sensing Self
    • 22.20. PTE. Ltd
    • 22.21. Atomo Diagnostics
    • 22.22. Mankind Pharma
  • 23. Assumptions and Acronyms Used
  • 24. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

At-home Molecular Testing Market

Schedule a Call